SALT LAKE CITY, UT / ACCESS Newswire / September 25, 2026 / (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC athttps://www.
Utah Medical Products Inc (NASDAQ:UTMD) recently announced a total dividend of $0.31 per share. The ex-dividend date is set for 2026-09-17, and the cash dividend of $0.31 per share is payable on 2026-10-05. For investors, the ex-dividend date is the cutoff: shareholders must own the stock before this date to qualify for the payment, while the paydate marks when the cash actually arrives.
SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.
Utah Medical Products' (UTMD) Femcare subsidiary said Monday that it has acquired UK-based Orion Med
SALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 ...
UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
A physician explains Utah's program to let an AI chatbot renew prescriptions. Six months of data are now testing doctors, regulators and the FDA.
This is the newest page. Registered accounts read further back.